Tags

Type your tag names separated by a space and hit enter

The COVID-19 pandemic and its impact on substance use: Implications for prevention and treatment.
Psychiatry Res. 2020 07; 289:113096.PR

Abstract

The COVID-19 pandemic has brought major challenges to healthcare systems and public health policies globally, as it requires novel treatment and prevention strategies to adapt for the impact of the pandemic. Individuals with substance user disorders (SUD) are at risk population for contamination due to multiple factors-attributable to their clinical, psychological and psychosocial conditions. Moreover, social and economic changes caused by the pandemic, along with the traditional difficulties regarding treatment access and adherence-will certainly worsen during this period, therefore aggravate their condition. In addition, this population are potential vectors of transmission. In that sense, specific strategies for prevention and treatment must be discussed. health care professionals dealing with SUD must be aware of the risks and challenges they will meet during and after the COVID-19 outbreak. Addiction care must be reinforced, instead of postponed, in order to avoid complications of both SUD and COVID-19 and to prevent the transmission of coronavirus.

Authors+Show Affiliations

Center for Drug and Alcohol Research and Collaborating Center on Alcohol and Drugs, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil. Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil. Faculdade IBGEN, IBGEN Buzines School - Grupo Uniftec, Centro Universitário e Faculdades, Porto Alegre, RS, Brazil.Center for Drug and Alcohol Research and Collaborating Center on Alcohol and Drugs, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil. Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.Center for Drug and Alcohol Research and Collaborating Center on Alcohol and Drugs, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil. Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil. Universidade do Vale do Rio dos Sinos, São Leopoldo, RS, Brasil.Center for Drug and Alcohol Research and Collaborating Center on Alcohol and Drugs, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil. Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.Center for Drug and Alcohol Research and Collaborating Center on Alcohol and Drugs, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil. Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.Center for Drug and Alcohol Research and Collaborating Center on Alcohol and Drugs, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil. Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil. Department of Psychiatry, Kingston General Hospital, Queen's University, Kingston, ON, Canada.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32405115

Citation

Ornell, Felipe, et al. "The COVID-19 Pandemic and Its Impact On Substance Use: Implications for Prevention and Treatment." Psychiatry Research, vol. 289, 2020, p. 113096.
Ornell F, Moura HF, Scherer JN, et al. The COVID-19 pandemic and its impact on substance use: Implications for prevention and treatment. Psychiatry Res. 2020;289:113096.
Ornell, F., Moura, H. F., Scherer, J. N., Pechansky, F., Kessler, F. H. P., & von Diemen, L. (2020). The COVID-19 pandemic and its impact on substance use: Implications for prevention and treatment. Psychiatry Research, 289, 113096. https://doi.org/10.1016/j.psychres.2020.113096
Ornell F, et al. The COVID-19 Pandemic and Its Impact On Substance Use: Implications for Prevention and Treatment. Psychiatry Res. 2020;289:113096. PubMed PMID: 32405115.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The COVID-19 pandemic and its impact on substance use: Implications for prevention and treatment. AU - Ornell,Felipe, AU - Moura,Helena Ferreira, AU - Scherer,Juliana Nichterwitz, AU - Pechansky,Flavio, AU - Kessler,Felix Henrique Paim, AU - von Diemen,Lisia, Y1 - 2020/05/13/ PY - 2020/04/13/received PY - 2020/05/09/revised PY - 2020/05/10/accepted PY - 2020/5/15/pubmed PY - 2020/9/12/medline PY - 2020/5/15/entrez SP - 113096 EP - 113096 JF - Psychiatry research JO - Psychiatry Res VL - 289 N2 - The COVID-19 pandemic has brought major challenges to healthcare systems and public health policies globally, as it requires novel treatment and prevention strategies to adapt for the impact of the pandemic. Individuals with substance user disorders (SUD) are at risk population for contamination due to multiple factors-attributable to their clinical, psychological and psychosocial conditions. Moreover, social and economic changes caused by the pandemic, along with the traditional difficulties regarding treatment access and adherence-will certainly worsen during this period, therefore aggravate their condition. In addition, this population are potential vectors of transmission. In that sense, specific strategies for prevention and treatment must be discussed. health care professionals dealing with SUD must be aware of the risks and challenges they will meet during and after the COVID-19 outbreak. Addiction care must be reinforced, instead of postponed, in order to avoid complications of both SUD and COVID-19 and to prevent the transmission of coronavirus. SN - 1872-7123 UR - https://www.unboundmedicine.com/medline/citation/32405115/The_COVID_19_pandemic_and_its_impact_on_substance_use:_Implications_for_prevention_and_treatment_ DB - PRIME DP - Unbound Medicine ER -